The health-tech newsletter for insiders and operators

The Roundup: The 5 Stories Driving Health-Tech in August plus a conversation with the CCO at Teletracking

Yaccarino's new role, Meta's data fine, Big Pharma going DTC and CVS's 20b bet, big funding rounds, etc

The lesson from Figma: Keep the faith

Healthcare companies - and their boards - should get inspired by this tortoise that beat all the hares

Healthtech Roundup: Humana bucks the trend, WH inroads to Healthtech, and a megaround for Ambience Healthcare.

5 areas of healthcare that are hot now because of AI

AI is going to have the biggest impact in areas of healthcare that were previously under-funded

Healthtech Roundup: Mega-rounds for Slingshot, AI Doc and Open Evidence, fallout from OBBB, and 4 questions with the Baptist Health CIO

AI continues attracting the lions share of investment in healthtech

Digital health has a new strategy: ‘First, get in-network!’

Maybe going direct to employers isn't the fastest path to success

Healthtech Roundup: All that's interesting about the last week + 4 questions with Brightside COO

Whoop battles the FDA, Lyra makes an acquisition, some interesting hires + founder dating too!

Healthtech Roundup: Deals, partnerships and other news you should know + 4 questions with Oura's Chief Medical Officer

The healthtech news you shouldn't miss for July 11 2025

Subscription-based healthcare just got a big tailwind

‘One Big, Beautiful Bill’ did a solid for direct primary care, longevity and telehealth, which may open up the employer channel in a big way for some digital health companies

Andreessen's Former Health Editorial Lead on why Founder-led PR is a Competitive Superpower

It's especially true in the age of AI, argue's Olivia Webb Kosloff

Healthtech Roundup: The big bill, CMS gets WISeR and more

I read all of the news so you don't have to

How healthcare VC firms are thinking about longevity

7wire shared their thesis and market map with us that it created for its own LPs

Weekly News: The HIMs/Novo breakup, digital health reimbursements and new funding rounds

Drama between an online prescriber and the pharma company was the most interesting drama of the week